In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...
A preclinical study by HSS investigators found that earlier anterior cruciate ligament (ACL) reconstruction led to lower ...
These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...
Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating ...
MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...
This collaboration will involve implementing the Aiforia ® Studies module within Orion's preclinical histology processes, as well as joint development to further automate and improve the study ...
Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company' or 'Polyrizon'), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results